Sort
40,608 grants matching “prostate cancer”
Polarized Probe for Fiberoptic In-Vivo Spectroscopy
$708,574Randal B Chinnock · Optimum Technologies, Inc. · R44 · FY2006 · CA
Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study
$708,444Allison W. Kurian · Stanford University · R01 · FY2024 · CA
The Molecular Profile of Prostate Tumors in African-American Men
$708,426Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Maryland Prostate Cancer Case-Control Study
$708,426Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
$708,273Christian J Nelson · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Harnessing ectonucleotidases to treat chronic pain
$708,206Mark J Zylka · Univ Of North Carolina Chapel Hill · R01 · FY2013 · NS
Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer
$707,952Adam S Kibel · Brigham And Women'S Hospital · U01 · FY2025 · CA
DEVELOPMENT OF MULTIPARAMETRIC MRI MODEL OF CLINICALLY SIGNIFICANT PROSTATE CANCER
$707,678Regents Of The University Of Minnesota · · FY2015 · Department of the Army
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
$707,429Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Population Modeling of Bladder Cancer Detection and Control
$707,395Thomas Trikalinos · Brown University · U01 · FY2021 · CA
SAN ANTONIO CENTER OF BIOMARKERS OF RISK FOR PROSTATE CA
$707,281University Of Texas Hlth Sci Ctr San Ant · U01 · FY2002 · CA
Phase II Clinical Trial of Polyphenon E in Prostate Cancer
$707,275Nagi B Kumar · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2009 · CA
Ultrasound imaging and local drug delivery in tumors
$707,248Katherine W Ferrara · University Of California At Davis · R01 · FY2011 · CA
ONCOGENICITY AND SELECTIVE INHIBITION OF ERG SPLICING VARIANTS IN PROSTATE CANCER
$707,118Sloan-Kettering Institute For Cancer Research · · FY2009 · Department of the Army
VITAMIN D AND RELATED GENES, RACE, AND PROSTATE CANCER AGGRESSIVENESS
$706,958South Carolina Research Foundation · · FY2011 · Department of Defense
Detection of metastases in lymph nodes using quantitative ultrasound
$706,909Ernest Joseph Feleppa · Riverside Research Institute · R01 · FY2016 · CA
The MB-CCOP at Boston Medical Center
$706,684Lisa A. Kachnic · Boston Medical Center · U10 · FY2010 · CA
A Platform for Cancer Biomarker Validation: Image Fusion Using NIR Fluorescence
$706,671John V Frangioni · Beth Israel Deaconess Medical Center · R01 · FY2011 · CA
PLCO EEMS and Extended Follow Up
$706,495Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
Stroger Hospital of Cook County, Department of Surgery,*
$706,480Thomas Lad · Hektoen Institute For Medical Research · U10 · FY2008 · CA
Identification of genomic markers for disease progression in cervical, breast an
$706,409Thomas Ried · Basic Sciences · Z01 · FY2007 · CA
(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection
$706,386Elizabeth Chiao · Baylor College Of Medicine · R01 · FY2018 · CA
Core 1
$706,228Ann G Schwartz · Wayne State University · P01 · FY2024 · CA
Understanding and addressing rejection of personalized cancer risk information
$706,184Laura D. Scherer · University Of Colorado Denver · R01 · FY2024 · CA
Integrated radiomic and liquid biopsy monitoring in SWOG S1802: A phase 3 therapeutic trial for metastatic prostate cancer
$706,071Amir Goldkorn · University Of Southern California · R01 · FY2021 · CA